secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEVRO CORP (—)
CIK:        0001444380
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001193125-25-071904
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Completed acquisition by Globus Medical for $5.85/share; Nevro now wholly owned subsidiary
--------------------------------------------------------------------------------

- Holders of Nevro shares received $5.85 per share in cash; stock options and RSUs cancelled for cash.
- On April 1, Nevro repaid ~$190M principal plus ~$2.61M accrued interest on 2.75% Convertible Senior Notes.
- Nevro terminated its $200M Credit Agreement, paying ~$227.1M including principal, interest, and fees.
- All Nevro directors resigned; Globus designees installed. Nevro requested delisting from NYSE and plans to deregister.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444380/000119312525071904/0001193125-25-071904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444380/000119312525071904/d912761d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-071904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer